The FDA clearance follows the presentation of SANSA clinical performance data earlier this year at the SLEEP meeting. The study, drawing on data collected from 325 patients across 7 clinical sites, ...
The MarketWatch News Department was not involved in the creation of this content. ATLANTA, Dec. 17, 2025 /PRNewswire/ -- Huxley Medical, Inc. today announced the U.S. Food and Drug Administration (FDA ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results